đź’¨ Abstract
CytomX Therapeutics Inc. (CTMX) reported a first-quarter net income of $23.5 million, exceeding Wall Street expectations. The company earned 27 cents per share, surpassing the estimated 18 cents, and reported $50.9 million in revenue, higher than the forecasted $35.5 million. Additionally, in a separate news alert, the U.S.
Courtesy: wtop.com
Summarized by Einstein Beta 🤖
Suggested
Trump anuncia en redes sociales un decreto que busca reducir los precios de los medicamentos -
Expressions you use every day and where they come from -
MartĂn Goerling: Ficha Limpia “es tan importante, que discutirla en el marco de las elecciones en CABA, es tomar el pelo” -
An airstrike in central Myanmar kills up to 22 people at a bombed school, reports say -
Cuatro en la tabla: quién será el eliminado de La Casa de los Famosos All-Stars
NASCAR star Kyle Larson is ready to focus on the Indianapolis 500 — after a sprint car race -
$250 fines begin for passing stopped school buses in Fairfax County -
Federico DomĂnguez, consultor financiero: “Argentina necesita remonetizarse y necesita los dĂłlares del colchĂłn” -
The Eurovision Song Contest is back. Here’s how and who to watch -
The Latest: The White House releases Trump’s schedule for Monday -
Powered by MessengerX.io